Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Secondary Acute Myelogenous Leukemia Evolving From Myeloproliferative Disorder × Myeloid × 30 days × Clear all

Sponsor

Conditions

Myelodysplastic Syndromes 75 Leukemia, Myeloid, Acute 67 Myeloproliferative Disorders 34 Leukemia, Myelomonocytic, Chronic 25 Precursor Cell Lymphoblastic Leukemia-Lymphoma 21 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 20 Primary Myelofibrosis 18 Polycythemia Vera 12 Leukemia, Biphenotypic, Acute 12 Myelodysplastic-Myeloproliferative Diseases 11 Leukemia 11 Thrombocythemia, Essential 10 Anemia, Refractory, with Excess of Blasts 10 Neoplasms 8 Multiple Myeloma 7 Lymphoma, Non-Hodgkin 7 Hematologic Neoplasms 7 Hematologic Diseases 7 Lymphoma 6 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 5 Hodgkin Disease 5 Histiocytosis, Langerhans-Cell 5 Bone Marrow Diseases 5 Recurrence 4 Neoplasms by Histologic Type 4 Mastocytosis 4 Lymphoproliferative Disorders 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Sarcoma 3 Rhabdoid Tumor 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡